论文部分内容阅读
乙型肝炎病毒(HBV)携带者在全球已高达3.5亿人,其中60%分布在亚太地区,据统计,我国有1.3亿人携带HBV。由于人们的个体差异反应,感染HBV后可出现不同的免疫应答反应,乙型肝炎5项定量检测结果出现不同的免疫模式。荧光定量聚合酶链反应(RT-PCR)是从分子生物学水平直接检测HBV-DNA,具有高度的敏感性和特异性,目前已广泛
Hepatitis B virus (HBV) carriers in the world has reached 350 million people, of which 60% are distributed in the Asia Pacific region, according to statistics, 130 million people in our country carry HBV. Due to the individual differences in people’s responses, different immune responses may occur after HBV infection, and different quantitative immunodetection patterns may be found in the five quantitative hepatitis B tests. Fluorescent quantitative polymerase chain reaction (RT-PCR) is a highly sensitive and specific method for the direct detection of HBV-DNA from molecular biology levels and is now widely available